Skip to Main Content

Advertisement

Skip Nav Destination

Correction: Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program

Clin Cancer Res (2017) 23 (4): 1118–1119.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Stefan K. Zöllner
  • James F. Amatruda
  • Sebastian Bauer
  • Stéphane Collaud
  • Enrique de Álava
  • Steven G. DuBois
  • Jendrik Hardes
  • Wolfgang Hartmann
  • Heinrich Kovar
  • Markus Metzler
  • David S. Shulman
  • Arne Streitbürger
  • Beate Timmermann
  • Jeffrey A. Toretsky
  • Yasmin Uhlenbruch
  • Volker Vieth
  • Thomas G. P. Grünewald
  • Uta Dirksen
Journal of Clinical Medicine (2021) 10 (8): 1685.
  • Jose Duran Moreno
  • Georgios Papageorgiou
  • Ioanna Gazouli
  • Anastasios Kyriazoglou
Forum of Clinical Oncology (2021) 12 (3): 3.
Close Modal

or Create an Account

Close Modal
Close Modal